meaningful use & cqm: c urrent and future guidance sanjaya kumar, md, m.sc., mph chief medical...

35
MEANINGFUL USE & CQM: CURRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2, 2011

Upload: leo-dawson

Post on 31-Dec-2015

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

MEANINGFUL USE & CQM:CURRENT AND FUTURE

GUIDANCE

Sanjaya Kumar, MD, M.Sc., MPH

Chief Medical Officer, Xstor Medical Systems

MHA Conference

August 2, 2011

Page 2: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

CURRENT STATE OF AFFAIRS:

Currently the US system is:Expensive: We spend more on healthcare

than any other nation (> 20% of GDP) Ineffective: Low quality and inadequate

outcomes on standards comparable to other countries

Fraught with high rates of medical errorsNot universally availableStructured in a manner unsupportable with

impending workforce shortages

Page 3: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

THE AMERICAN RECOVERY AND REINVESTMENT ACT (ARRA) & HIT

$36 billion investment by the Federal Government in Health IT. $2 billion in grant funds for HIE and for

technical assistance to providers. $34 billion paid out directly to

providers who prove “meaningful use” of a “certified” EHR system.HospitalsHealthcare practitioners

Page 4: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

WHERE IS MU TODAY…?

Starting in 2011, providers (EPs) and hospitals (including CAHs) can receive incentive payments from Medicare and Medicaid if they achieve “Meaningful Use” of a certified electronic health record. 

On July 13, 2010, the Centers for Medicare & Medicaid Services released the final rule defining the requirements for meaningful use in 2011 and 2012.  The rules contain more flexibility than those originally

proposed, but the basic elements are unchanged Health organizations need to quickly assess their gaps

in meaningful use and make sure their systems will be certified

See Update Document from CSC (2010)

Page 5: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

2011/2012: STAGE 1 In this Stage the focus is on data capture

In most cases this is necessitating adding modules to existing clinical information systems

For Stage 1 Incentive payments hospitals must meet:14 mandatory and 5 of 10 other requirements to demonstrate

meaningful use The requirements for Stage 2 include demonstration

that the EHR has been integrated into transformed processes and are used in health information exchange.

For Stage 3, the emphasis shifts to achieving improved outcomes with new care processes enabled by the EHR

Page 6: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

FEDERAL CHAIN OF COMMANDHealth and Human Services Secretary

Reviews ONC endorsements and approves adoptionCollaborates with CMS in the rule making process

Office of the National Coordinator (ONC)

•$2 billion•Regional Extension Centers•Electronic health record (EHR) Loan Fund•Health Information Exchange

Centers for Medicare and Medicaid Services (CMS)

•$34 billion •Medicare/Medicaid EHR incentives for meaningful use

Page 7: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

FLOW OF FUNDS

Office of the National Coordinator (ONC) Regional Extension Centers

Local Extension Centers Service Providers

EHR Loan Fund - On hold Health Information Exchange

Local health information organizations

Centers for Medicare and Medicaid Services (CMS) Medicare Incentives

Eligible providers who choose the Medicare MU $$ Medicaid Incentives

State Medicaid Offices (Eligible Professionals)

Page 8: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

WHY THE EMPHASIS ON HIT?

HIT and EHRs have the POTENTIAL to: Reduce costs Improve the quality of care by delineating areas for

improvement Save lives Improve access Redesign the work of providers to focus on critical

activities

Health IT has the potential to save the federal government more than $12 billion over 10 years, improve the quality of care, and make our health-care system efficient”(Dr. David Blumenthal, the National Coordinator of Health IT)

Page 9: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

ADDRESSING NATIONAL HEALTH POLICY GOALS

Meaningful Use Addresses Five National Health Policy Goals:

Improve quality, safety, efficiency, and reduce health disparities

Engage patients and families

Improve care coordination

Improve population and public health

Ensure adequate privacy and security protections for personal health information

Page 10: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

MORE WORK FOR THE GUYS IN THE BACK ROOM

The HIT phase ushered in by ARRA and MU is highly complex, which is illustrated by the plethora of acronyms emerging!

When discussing meaningful use of EHRs, in order to not go crazy, humor helps: HITECH: An Interoperetta in Three Acts

http://www.youtube.com/watch?v=Gv1s8fM3mMk

Page 11: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

SUMMARY OF FINAL STAGE 1 MEANINGFUL USE CRITERIA & REQUIREMENTS:

NOTE: REQUIREMENTS FOR HOSPITALS USE MEASURES BASED ON PERCENTAGE (INPATIENT AND EMERGENCY DEPARTMENT, EXCEPT AS NOTED)

Page 12: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

STAGE 1 REQUIREMENTS FUNCTIONAL REQUIREMENTS

Computerized Physician Order Entry (Mandatory) >30 percent of patients with medication orders

have at least one order entered via CPOE Medication Reconciliation (Optional)

Performed at >50 percent of admissions and transition from one care setting to another

Physician Documentation For >80 percent of all patients (Mandatory):

Maintain an up-to-date diagnosis/problem list of current and active diagnoses (ICD-9-CM or SNOMED CT)

Maintain active medication list Maintain active medication allergy list

All recorded as structured data (Optional)

Page 13: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

STAGE 1 REQUIREMENTS FUNCTIONAL REQUIREMENTS Other Documentation

Record demographics for >50 percent of admitted patients (Mandatory) Preferred language, gender Ethnicity, race, date of birth Date of death and preliminary cause, if applicable

Record vital signs for >50 percent of admitted patients ≥ 2 years of age (Mandatory) Height, weight, BP Display BMI Display growth chart, including BMI (pt 2-20 years)

For >50 percent of patients record smoking status (pt > 13 years) (Mandatory)

Incorporate clinical laboratory test results into EHR as structured data for >40 percent of all clinical lab tests ordered with positive/negative or numeric results (Optional)

For >50 percent of hospital patients over age 65, record whether the patient has an advanced directive (Optional)

Page 14: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

STAGE 1 REQUIREMENTS FUNCTIONAL REQUIREMENTS

Performance ImprovementDrug-drug and drug-allergy checks enabled

(Mandatory)Drug formulary checks enabled (Optional) Implement at least one clinical decision

support rule relevant to high clinical priority (Mandatory)

Generate at least one list of patients by specific conditions to use for quality improvement, reduction of disparities, outreach, etc. (Optional)

Page 15: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

STAGE 1 REQUIREMENTS FUNCTIONAL REQUIREMENTS

Performance Measurement/Reporting (Mandatory)Report hospital quality measures to CMS or

the states (if only qualifying for Medicaid) for 15 measures use of certified EHR technology for data capture, calculation and reporting For 2011: attest to accuracy and completeness of

aggregate numerator, denominator and exclusions For 2012: submit electronically

Page 16: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

STAGE 1 REQUIREMENTS HEALTH INFORMATION EXCHANGE

Health Information Exchange: PatientsProvide >50 percent of patients who request

it with an electronic copy of their health information (diagnostic test results, problem list, medication and allergy lists) within 3 business days (Mandatory)

Provide >50 percent of patients requesting discharge instructions with an electronic copy of their discharge instructions at the time of discharge (Mandatory)

Use EHR to identify appropriate education materials and provide to 10 percent of patients (Optional)

Page 17: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

STAGE 1 REQUIREMENTS HEALTH INFORMATION EXCHANGE

Health Information Exchange: External ProvidersPerform at least one test of the capability to

exchange key clinical information (e.g., discharge summary, procedures, problem list, medication list, allergies, test results) among providers belonging to different legal entities using different EHR systems (Mandatory)

Provide summary care record for >50 percent of patients for transitions in care and referrals (does not have to be electronic) (Optional)

Page 18: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

STAGE 1 REQUIREMENTS HEALTH INFORMATION EXCHANGE Health Information Exchange: Public Health

Authorities (Mandatory) Perform at least one test of the capability to submit

electronic data to immunization registries where required and accepted

Perform at least one test of the capability to provide electronic submission of reportable lab results (as required by state or local law) to public health agencies where it can be received

Perform at least one test of the capability to provide electronic surveillance data to public health agencies where it can be received

Page 19: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

STAGE 1 REQUIREMENTS PRIVACY & SECURITY

Perform a security risk analysis before every qualifying year and implement needed changes (Mandatory)

Page 20: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

EMR ADOPTION…SLOW PROGRESS…

EHR Implementation in U.S. Hospitals Comprehensive, used on all units 1.5% CPOE for medications 17% Physician notes 12% Problem list 27% Clinical guidelines (post-AMI care) 17%

Page 21: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

SUMMARY OF CLINICAL QUALITY MEASUREMENT COMPONENTS FOR MU

SEE CMS FOR CURRENT DETAILS: HTTP://WWW.CMS.GOV/QUALITYMEASURES/03_ELECTRONICSPECIFICATIONS.ASP

Page 22: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

ELECTRONIC SPECIFICATIONS FOR CLINICAL QUALITY MEASURES

To report clinical quality measures (CQMs) from an electronic health record (EHR), electronic specifications must be developed that include the data elements, logic and definitions for that measure in a format that can be captured or stored in the EHR so that the data can be sent or shared electronically with other entities in a structured, standardized format, and in an unaltered form.

Page 23: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

CQM ELECTRONIC SPECIFICATION COMPONENTS Measure Overview/Description - This contains the measure

title, description, number, measurement period, measure steward, and other relevant information to the measure.

Measure Logic - This contains the population criteria and measure logic for the numerator, denominator and exclusion categories. The measure logic contains the algorithm used to calculate performance.

Measure Code Lists - This contains all of the codes pertaining to the measure.

QDS Elements - This lists and describes each Quality Data Set (QDS) data element associated with the measure. The QDS is a model of information that contains the standard

element, the quality data element, and the data flow attributes. The QDS model also describes information in a manner that

allows EHR and other clinical electronic system vendors to unambiguously interpret the data and clearly locate the data required.

Page 24: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

CQM REPORTING REQUIREMENTS BY ELIGIBLE PROFESSIONALS (EP) Eligible professionals must report from a total of

44 clinical quality measures which includes, 3 Core, 3 Alternate Core, and 38 additional CQMs. Core CQMs - EPs must report on 3 required core CQMs,

and if the denominator of 1 or more of the required core measures is 0, then EPs are required to report results for up to 3 alternate core measures.

EPs also must also select 3 additional CQMs from a set of 38 CQMs (excluding the core/alternate core measures). For these measures it is acceptable to have a '0'

denominator provided the EP does not have an applicable population.

Page 25: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

REQUIRED CQM REPORTING BY EPS:

EPs must report on:6 total measures: 3 required core

measures (substituting alternate core measures where necessary) and 3 additional measures.

Note: A maximum of 9 measures would be reported if the EP needed to attest to the 3 required core, the three alternate core, and the 3 additional measures.

Page 26: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

CQM REPORTING REQUIREMENTS BY ELIGIBLE HOSPITALS & CAHS

Hospitals & CAHs wanting to join the MU incentive program need to report on 15 CQMs

Measures focusing on:Quality deficits in evidence based careHigh variation among practitionersInappropriate utilization of servicesHigh costs to system

Page 27: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

HOSPITAL CQM SUMMARY SPECIFICATIONSMeasure Number Brief Description

STK-1 Ischemic and hemorrhagic stroke patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission

STK-2 Ischemic stroke patients prescribed antithrombolytic therapy at hospital discharge

STK-3 Ischemic stroke patients with atrial fibrillation/flutter who are prescribed anticoagulation therapy at hospital discharge

STK-4 Acute ischemic stroke patients who arrive at this hospital within 2 hours of time last known well and for whom IV t-PA was initiated at this hospital within 3 hours of time last known well

STK-5 Ischemic stroke patients administered antithrombolytic therapy by the end of hospital day 2

STK-6 Ischemic stroke patients with LDL >= 100 mg/dL, or LDL not measured, or, who were on a lipid-lowering medication prior to hospital arrival are prescribed statin medication at hospital discharge.

STK-8 Ischemic or hemorrhagic stroke patients or their caregivers who were given educational materials during the hospital stay addressing all of the following: activation of emergency medical system, need for follow-up after discharge, medications prescribed at discharge, risk factors for stroke, and warning signs and symptoms of stroke

STK-10 Ischemic or hemorrhagic stroke patients who were assessed for rehabilitation services

Page 28: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

HOSPITAL CQM SUMMARY SPECIFICATIONS

Measure Number Brief Description VTE-1 […patients] who received VTE prophylaxis or have documentation why

no VTE prophylaxis was given the day of or the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission

VTE-2 […patients] who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after the initial

admission (or transfer) to the Intensive Care Unit (ICU) or surgery end date for surgeries that start the day of or the day after ICU admission (or transfer)

VTE-3 […patients] diagnosed with confirmed VTE who received an overlap of parenteral (intravenous [IV] or subcutaneous [subcu]) anticoagulation and

warfarin therapy. For patients who received less than five days of overlap therapy, they must be discharged on both medications. Overlap therapy must be administered for at least five days with an international normalized ratio (INR) ≥ 2 prior to discontinuation of the parenteral anticoagulation therapy or the patient must be discharged on both medications

VTE-4 […patients] diagnosed with confirmed VTE who received intravenous (IV) UFH therapy dosages AND had their platelet counts monitored using

defined parameters such as a nomogram or protocol VTE-5 […patients] diagnosed with confirmed VTE that are discharged to home, to

home with home health or home hospice on warfarin with written discharge instructions that address all four criteria: compliance issues,

dietary advice, follow-up monitoring and information about the potential for adverse drug reactions/interactions

VTE-6 […patients] diagnosed with confirmed VTE during hospitalization (not present on arrival) who did not receive VTE prophylaxis between hospital admission and the day before the VTE diagnostic testing order date

Page 29: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

HOSPITAL CQM SUMMARY SPECIFICATIONS

Measure Number Brief Description ED-1 Median time from emergency

department arrival to time of departure from the emergency room for patients admitted to the facility from the emergency department

ED2 Median time from admit decision time to time of departure from

the emergency department for emergency department patients admitted to inpatient status

Page 30: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

ARRA & MEDICARE

Medicare Incentive Payments for Hospitals Hospitals can receive up to $8 million over four

years if they are using health IT starting in 2011 Paid only a pro-rated amount of the total based

on Medicare share and transition factor Critical Access Hospitals are eligible for

incentives that cover actual costs based on Medicare share plus 20% Covers an average of 86% of allowed costs

Medicare payments reduced for non-users beginning in 2015

Page 31: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

REPORTING PERIOD

The reporting period for the EHR Incentive program using a certified EHR is any continuous 90 day period during the first payment year.

Note: Although the measure specifications assume a full calendar year you should only calculate the denominator and numerator from the first day of the 90 day reporting period to the last day of the 90 day reporting period.

Page 32: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

GETTING IT DONE…

Do not wait for further information to get started – it is what needs to be done.

Send a clear message from the executive suite — both in words and through personal involvement — that this is the right thing to do for patients and a must for the hospital's future.

Achieving meaningful use is a huge clinical and operational change project. Put clinical and operational executives in the lead and make them accountable for success.

Work toward meaningful use as a highly coordinated effort rather than as a series of separate projects.

Page 33: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

GETTING IT DONE…

Devil is in the details — process nuances, data and EHR functions. Commit sufficient time and resources to ensure they are addressed in a way that is workable for every patient care unit and support clinician workflow.

Business as usual in tackling process improvement — a prolonged consensus building process — takes too much time: Learn from the experience of others and make key strategic

decisions upfront to guide the process and empower knowledgeable, credible representatives of departments and clinicians to decide on the operational and tactical details.

Workarounds abound and "our unit is different" is often a long-held belief. Be prepared to take a hard line on standardized practices

that are in line with industry best practices.

Page 34: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

GETTING IT DONE…

There is no time for multiple iterations and rework.

Include front-line users and even patients in order to increase adoption of modules that require re-engineered work flow – change management a key to success

Get it right the first time No time for work arounds

Page 35: MEANINGFUL USE & CQM: C URRENT AND FUTURE GUIDANCE Sanjaya Kumar, MD, M.Sc., MPH Chief Medical Officer, Xstor Medical Systems MHA Conference August 2,

QUESTIONS

Contact Information:[email protected]

Authored Books:Demand Better! – Released April 2011Fatal Care – Released 2009

www.fatalcare.com